• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对癌症干性相关信号通路的治疗靶向作用

Therapeutic Targeting of Signaling Pathways Related to Cancer Stemness.

作者信息

Espinosa-Sánchez Asunción, Suárez-Martínez Elisa, Sánchez-Díaz Laura, Carnero Amancio

机构信息

Instituto de Biomedicina de Sevilla (IBIS), Hospital Universitario Virgen del Rocío, Universidad de Sevilla, Consejo Superior de Investigaciones Científicas, Seville, Spain.

CIBER de Cancer, Madrid, Spain.

出版信息

Front Oncol. 2020 Aug 26;10:1533. doi: 10.3389/fonc.2020.01533. eCollection 2020.

DOI:10.3389/fonc.2020.01533
PMID:32984007
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7479251/
Abstract

The theory of cancer stem cells (CSCs) proposes that the different cells within a tumor, as well as metastasis deriving from it, are originated from a single subpopulation of cells with self-renewal and differentiation capacities. These cancer stem cells are supposed to be critical for tumor expansion and metastasis, tumor relapse and resistance to conventional therapies, such as chemo- and radiotherapy. The acquisition of these abilities has been attributed to the activation of alternative pathways, for instance, WNT, NOTCH, SHH, PI3K, Hippo, or NF-κB pathways, that regulate detoxification mechanisms; increase the metabolic rate; induce resistance to apoptotic, autophagic, and senescence pathways; promote the overexpression of drug transporter proteins; and activate specific stem cell transcription factors. The elimination of CSCs is an important goal in cancer therapeutic approaches because it could decrease relapses and metastatic dissemination, which are main causes of mortality in oncology patients. In this work, we discuss the role of these signaling pathways in CSCs along with their therapeutic potential.

摘要

癌症干细胞(CSCs)理论提出,肿瘤内的不同细胞以及源自肿瘤的转移灶均起源于具有自我更新和分化能力的单个细胞亚群。这些癌症干细胞被认为对肿瘤的扩展和转移、肿瘤复发以及对化疗和放疗等传统疗法的抗性至关重要。这些能力的获得归因于替代途径的激活,例如WNT、NOTCH、SHH、PI3K、Hippo或NF-κB途径,这些途径调节解毒机制;提高代谢率;诱导对凋亡、自噬和衰老途径的抗性;促进药物转运蛋白的过表达;并激活特定的干细胞转录因子。消除癌症干细胞是癌症治疗方法中的一个重要目标,因为它可以减少复发和转移性扩散,而这是肿瘤患者死亡的主要原因。在这项工作中,我们讨论了这些信号通路在癌症干细胞中的作用及其治疗潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca83/7479251/376922edd6cd/fonc-10-01533-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca83/7479251/07a5f46b0dfd/fonc-10-01533-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca83/7479251/8f439782fcdf/fonc-10-01533-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca83/7479251/4617ff759402/fonc-10-01533-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca83/7479251/63e7f4563b0c/fonc-10-01533-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca83/7479251/543923b95ff1/fonc-10-01533-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca83/7479251/7183faf17e00/fonc-10-01533-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca83/7479251/376922edd6cd/fonc-10-01533-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca83/7479251/07a5f46b0dfd/fonc-10-01533-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca83/7479251/8f439782fcdf/fonc-10-01533-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca83/7479251/4617ff759402/fonc-10-01533-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca83/7479251/63e7f4563b0c/fonc-10-01533-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca83/7479251/543923b95ff1/fonc-10-01533-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca83/7479251/7183faf17e00/fonc-10-01533-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca83/7479251/376922edd6cd/fonc-10-01533-g0007.jpg

相似文献

1
Therapeutic Targeting of Signaling Pathways Related to Cancer Stemness.针对癌症干性相关信号通路的治疗靶向作用
Front Oncol. 2020 Aug 26;10:1533. doi: 10.3389/fonc.2020.01533. eCollection 2020.
2
Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications.调控乳腺癌干细胞维持的信号通路及其治疗意义。
Front Cell Dev Biol. 2023 Jul 10;11:1221175. doi: 10.3389/fcell.2023.1221175. eCollection 2023.
3
Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.电离辐射诱导癌细胞发生转移、癌症干细胞表型及致癌代谢。
Mol Cancer. 2017 Jan 30;16(1):10. doi: 10.1186/s12943-016-0577-4.
4
Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.癌症干细胞:获取、特征、治疗意义、靶向策略和未来前景。
Stem Cell Rev Rep. 2019 Jun;15(3):331-355. doi: 10.1007/s12015-019-09887-2.
5
Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.癌症干细胞的起源和生物标志物:靶向个体化治疗的新视角。
Front Immunol. 2020 Aug 7;11:1280. doi: 10.3389/fimmu.2020.01280. eCollection 2020.
6
Inhibition of NF-κB Signaling Reduces the Stemness Characteristics of Lung Cancer Stem Cells.抑制NF-κB信号传导可降低肺癌干细胞的干性特征。
Front Oncol. 2018 May 17;8:166. doi: 10.3389/fonc.2018.00166. eCollection 2018.
7
Resistance to Cell Death and Its Modulation in Cancer Stem Cells.癌症干细胞中对细胞死亡的抗性及其调控
Crit Rev Oncog. 2016;21(3-4):203-219. doi: 10.1615/CritRevOncog.2016016976.
8
FZD7 accelerates hepatic metastases in pancreatic cancer by strengthening EMT and stemness associated with TGF-β/SMAD3 signaling.FZD7通过增强与TGF-β/SMAD3信号通路相关的上皮-间质转化和干性来加速胰腺癌肝转移。
Mol Med. 2022 Jul 19;28(1):82. doi: 10.1186/s10020-022-00509-1.
9
Mechanisms of cancer stem cell therapy.癌症干细胞治疗的机制。
Clin Chim Acta. 2020 Nov;510:581-592. doi: 10.1016/j.cca.2020.08.016. Epub 2020 Aug 11.
10
Cancer stem cells (CSCs) in cancer progression and therapy.癌症进展和治疗中的癌症干细胞 (CSCs)。
J Cell Physiol. 2019 Jun;234(6):8381-8395. doi: 10.1002/jcp.27740. Epub 2018 Nov 11.

引用本文的文献

1
Epithelial-Mesenchymal Transition in Cancer: Insights Into Therapeutic Targets and Clinical Implications.癌症中的上皮-间质转化:对治疗靶点及临床意义的见解
MedComm (2020). 2025 Aug 29;6(9):e70333. doi: 10.1002/mco2.70333. eCollection 2025 Sep.
2
Therapeutic and Prognostic Relevance of Cancer Stem Cell Populations in Endometrial Cancer: A Narrative Review.子宫内膜癌中癌症干细胞群的治疗及预后相关性:一项叙述性综述
Diagnostics (Basel). 2025 Jul 25;15(15):1872. doi: 10.3390/diagnostics15151872.
3
YAP as a therapeutic target in esophageal squamous cell carcinoma: insights and strategies.

本文引用的文献

1
p53 destabilizing protein skews asymmetric division and enhances NOTCH activation to direct self-renewal of TICs.p53 不稳定蛋白使不对称分裂倾斜,并增强 NOTCH 激活,以指导 TIC 的自我更新。
Nat Commun. 2020 Jun 17;11(1):3084. doi: 10.1038/s41467-020-16616-8.
2
PAWI-2 overcomes tumor stemness and drug resistance via cell cycle arrest in integrin β-KRAS-dependent pancreatic cancer stem cells.PAWI-2 通过整合素 β-KRAS 依赖性胰腺肿瘤干细胞的细胞周期停滞克服肿瘤干性和耐药性。
Sci Rep. 2020 Jun 8;10(1):9162. doi: 10.1038/s41598-020-65804-5.
3
ZSCAN4 facilitates chromatin remodeling and promotes the cancer stem cell phenotype.
YAP作为食管鳞状细胞癌的治疗靶点:见解与策略
Ann Med. 2025 Dec;57(1):2536200. doi: 10.1080/07853890.2025.2536200. Epub 2025 Jul 22.
4
Targeting stem-property and vasculogenic mimicry for sensitizing paclitaxel therapy of triple-negative breast cancer by biomimetic codelivery.通过仿生共递送靶向干细胞特性和血管生成拟态以增强三阴性乳腺癌的紫杉醇治疗效果
Acta Pharm Sin B. 2025 Jun;15(6):3226-3242. doi: 10.1016/j.apsb.2025.04.006. Epub 2025 Apr 10.
5
The Importance of Cancer Stem Cells and Their Pathways in Endometrial Cancer: A Narrative Review.癌症干细胞及其信号通路在子宫内膜癌中的重要性:一篇综述
Cells. 2025 Apr 14;14(8):594. doi: 10.3390/cells14080594.
6
Molecular mechanisms of Hippo pathway in tumorigenesis: therapeutic implications.Hippo信号通路在肿瘤发生中的分子机制:治疗意义
Mol Biol Rep. 2025 Feb 27;52(1):267. doi: 10.1007/s11033-025-10372-y.
7
Molecular Mechanisms of Dietary Compounds in Cancer Stem Cells from Solid Tumors: Insights into Colorectal, Breast, and Prostate Cancer.实体瘤癌症干细胞中膳食化合物的分子机制:对结直肠癌、乳腺癌和前列腺癌的见解
Int J Mol Sci. 2025 Jan 13;26(2):631. doi: 10.3390/ijms26020631.
8
Acetylated Globotetraose (Ac-Gb4) Suppresses Triple-Negative Breast Cancer Through FAK/AKT Signaling Pathway.乙酰化的球四糖(Ac-Gb4)通过FAK/AKT信号通路抑制三阴性乳腺癌。
Int J Mol Sci. 2024 Dec 12;25(24):13353. doi: 10.3390/ijms252413353.
9
The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterations.去分化过程驱动的表观遗传改变中肺癌干细胞的分子特征。
J Biol Chem. 2024 Dec;300(12):107994. doi: 10.1016/j.jbc.2024.107994. Epub 2024 Nov 14.
10
Reactive oxygen species from non-thermal gas plasma (CAP): implication for targeting cancer stem cells.非热气体等离子体(冷大气压等离子体)产生的活性氧:对靶向癌症干细胞的意义
Cancer Cell Int. 2024 Oct 22;24(1):344. doi: 10.1186/s12935-024-03523-x.
ZSCAN4 促进染色质重塑并促进癌症干细胞表型。
Oncogene. 2020 Jun;39(26):4970-4982. doi: 10.1038/s41388-020-1333-1. Epub 2020 Jun 7.
4
Genetic mutational analysis of β-catenin gene affecting GSK-3β phosphorylation plays a role in gallbladder carcinogenesis: Results from a case control study.影响GSK-3β磷酸化的β-连环蛋白基因的遗传突变分析在胆囊癌发生中起作用:一项病例对照研究的结果。
Cancer Treat Res Commun. 2020;23:100173. doi: 10.1016/j.ctarc.2020.100173. Epub 2020 Apr 21.
5
Intravesical Therapy for Non-muscle Invasive Bladder Cancer-Current and Future Options in the Age of Bacillus Calmette-Guerin Shortage.非肌层浸润性膀胱癌的膀胱内治疗——卡介苗短缺时代的当前及未来选择
Rev Urol. 2019;21(4):145-153.
6
TLR5 agonist entolimod reduces the adverse toxicity of TNF while preserving its antitumor effects.TLR5 激动剂恩利莫德减少了 TNF 的不良反应毒性,同时保留了其抗肿瘤作用。
PLoS One. 2020 Feb 6;15(2):e0227940. doi: 10.1371/journal.pone.0227940. eCollection 2020.
7
Blockade of TLR4 using TAK-242 (resatorvid) enhances anti-cancer effects of chemotherapeutic agents: a novel synergistic approach for breast and ovarian cancers.使用 TAK-242(resatorvid)阻断 TLR4 增强化疗药物的抗癌作用:乳腺癌和卵巢癌的一种新协同方法。
Immunol Res. 2019 Dec;67(6):505-516. doi: 10.1007/s12026-019-09113-8.
8
First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors.首例人类 NY-ESO-1 蛋白癌症疫苗的 I 期临床试验,该疫苗联合 NOD2 和 TLR9 激动剂,用于治疗表达 NY-ESO-1 的难治性实体肿瘤患者。
Cancer Immunol Immunother. 2020 Apr;69(4):663-675. doi: 10.1007/s00262-020-02483-1. Epub 2020 Jan 24.
9
The Tumor Suppressor Roles of MYBBP1A, a Major Contributor to Metabolism Plasticity and Stemness.MYBBP1A的肿瘤抑制作用,其对代谢可塑性和干性的主要贡献者
Cancers (Basel). 2020 Jan 20;12(1):254. doi: 10.3390/cancers12010254.
10
Fecal Microbiota Transplantation Prevents Intestinal Injury, Upregulation of Toll-Like Receptors, and 5-Fluorouracil/Oxaliplatin-Induced Toxicity in Colorectal Cancer.粪便微生物移植可预防结直肠癌患者的肠道损伤、Toll 样受体上调及氟尿嘧啶/奥沙利铂毒性。
Int J Mol Sci. 2020 Jan 8;21(2):386. doi: 10.3390/ijms21020386.